Quantcast
Last updated on April 24, 2014 at 21:24 EDT

Latest Piperazines Stories

2013-09-10 12:28:43

ALLEGAN, Mich., Sept. 10, 2013 /PRNewswire/ -- Perrigo Company (NYSE: PRGO; TASE) today announced that it has received final approval from the U.S. Food and Drug Administration for its abbreviated new drug application for cetirizine hydrochloride oral solution USP, 1 mg/mL, bubble gum flavored, the store brand equivalent to Children's Zyrtec® Allergy Syrup, 1 mg/mL, bubble gum flavored. Perrigo expects to begin shipments of the product during the upcoming cough/cold/flu...

2013-09-05 16:25:42

Data presented on results in healthy and infected animals, survival in combination with antibiotics, and development of adaptive immunity PINE BROOK, N.J. and VICTORIA, British Columbia, Sept. 5, 2013 /PRNewswire/ -- Elusys Therapeutics, Inc. (Elusys), a biopharmaceutical company developing antibody therapies to treat infectious disease, presented key findings from nonclinical studies evaluating the company's anthrax anti-toxin therapy, ETI-204 (Anthim), at the International...

2013-09-03 12:26:02

Consumers and Third-Party Payors Eligible to Receive Money from Class Action Antitrust Settlement with Bayer SAN DIEGO, Sept. 3, 2013 /PRNewswire-USNewswire/ -- The following is being released by the law firms of Lieff Cabraser Heimann & Bernstein, LLP, Zwerling, Schachter & Zwerling, LLP, the Joseph Saveri Law Firm, Inc., and Krause, Kalfayan Benink & Slavens, LLP. A partial settlement has been reached in a class action lawsuit involving the prescription antibiotic...

2013-08-29 23:30:41

Media health report cites problems with prescribing of antibiotics such as Zithromax by physicians. Resource4thePeople announces it will continue to provide free legal consultations about rights to legal compensation over allegations of dangerous side effects from the use of Zithromax and Zmax SR. San Diego, CA (PRWEB) August 29, 2013 http://www.resource4thepeople.com/defectivedrugs/Zithromax-lawsuits.html Resource4thePeople announced today its latest update for consumers keeping abreast...

2013-08-29 12:26:37

After identifying a protein that blocks death of high-risk acute lymphoblastic leukemia (ALL) cells, scientists use two-drug combination therapy to offer hope to children and adults with the disease MEMPHIS, Tenn., Aug. 29, 2013 /PRNewswire-USNewswire/ -- St. Jude Children's Research Hospital scientists have identified a protein that certain high-risk acute lymphoblastic leukemia (ALL) cells need to survive and have used that knowledge to fashion a more effective method of killing...

2013-08-22 12:27:32

The Launches of Several Depot Antipsychotics Will Help to Mitigate the Impact of Increasing Generic Competition, According to a New Report from Decision Resources BURLINGTON, Mass., Aug. 22, 2013 /PRNewswire/ -- Decision Resources, one of the world's leading research and advisory firms for pharmaceutical and healthcare issues, finds that Roche/Chugai's glycine transporter-1 inhibitor bitopertin is poised to be the first approved treatment to address negative symptoms in...

2013-08-22 10:29:47

Prescribing of "atypical" antipsychotic medications to children and young adults with behavioral problems or mood disorders may put them at unnecessary risk for type 2 diabetes, a Vanderbilt University Medical Center study shows. Young people using medications like risperidone, quetiapine, aripiprazol and olanzapine led to a threefold increased risk of developing type 2 diabetes within the first year of taking the drug, according to the study published Aug. 21 in the journal JAMA...

2013-08-20 08:29:22

Single administration of sustained-release antibiotic demonstrated clinically meaningful reduction in post-operative treatment failure SAN DIEGO, Aug. 20, 2013 /PRNewswire/ -- Otonomy, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics for diseases and disorders of the inner and middle ear, today announced positive results from a Phase 1b study of OTO-201 in pediatric patients undergoing tympanostomy tube placement (TTP) surgery. OTO-201 is Otonomy's...

2013-08-14 23:28:52

FDA soliciting adverse event reports over claims that DePuy Orthopaedics LPS Diaphyseal Knee Sleeve systems failed and may have caused serious side effects. Resource4thePeople continues to offer free consultations to consumers seeking information about legal options to seek compensation for alleged injuries. San Diego, CA (PRWEB) August 14, 2013 http://www.resource4thepeople.com/defectivemedicaldevices/depuy-knee-sleeve-lawsuits.html Resource4thePeople announced today that it is...

2013-07-30 08:34:45

Alexza's Partner Ferrer Records First Product Sales in Germany MOUNTAIN VIEW, Calif., July 30, 2013 /PRNewswire/ -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) today announced that the company's commercial partner Grupo Ferrer Internacional, S.A. has initiated sales of ADASUVE(®) inhalation powder, pre-dispensed (Staccato(®) Loxapine) in the European Union ("EU"). ADASUVE is now available in Germany. The first sale and shipment of product by Ferrer triggers a $1.25 million...